Menu
GWAS Study

Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis.

Kemp JP, Morris JA, Medina-Gomez C et al.

28869591 PubMed ID
GWAS Study Type
142487 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KJ
Kemp JP
MJ
Morris JA
MC
Medina-Gomez C
FV
Forgetta V
WN
Warrington NM
YS
Youlten SE
ZJ
Zheng J
GC
Gregson CL
GE
Grundberg E
TK
Trajanoska K
LJ
Logan JG
PA
Pollard AS
SP
Sparkes PC
GE
Ghirardello EJ
AR
Allen R
LV
Leitch VD
BN
Butterfield NC
KD
Komla-Ebri D
AA
Adoum AT
CK
Curry KF
WJ
White JK
KF
Kussy F
GK
Greenlaw KM
XC
Xu C
HN
Harvey NC
CC
Cooper C
AD
Adams DJ
GC
Greenwood CMT
MM
Maurano MT
KS
Kaptoge S
RF
Rivadeneira F
TJ
Tobias JH
CP
Croucher PI
AC
Ackert-Bicknell CL
BJ
Bassett JHD
WG
Williams GR
RJ
Richards JB
ED
Evans DM
Chapter II

Abstract

Summary of the research findings

Osteoporosis is a common disease diagnosed primarily by measurement of bone mineral density (BMD). We undertook a genome-wide association study (GWAS) in 142,487 individuals from the UK Biobank to identify loci associated with BMD as estimated by quantitative ultrasound of the heel. We identified 307 conditionally independent single-nucleotide polymorphisms (SNPs) that attained genome-wide significance at 203 loci, explaining approximately 12% of the phenotypic variance. These included 153 previously unreported loci, and several rare variants with large effect sizes. To investigate the underlying mechanisms, we undertook (1) bioinformatic, functional genomic annotation and human osteoblast expression studies; (2) gene-function prediction; (3) skeletal phenotyping of 120 knockout mice with deletions of genes adjacent to lead independent SNPs; and (4) analysis of gene expression in mouse osteoblasts, osteocytes and osteoclasts. The results implicate GPC6 as a novel determinant of BMD, and also identify abnormal skeletal phenotypes in knockout mice associated with a further 100 prioritized genes.

76,067 European ancestry women, 66,420 European ancestry men

Chapter III

Study Statistics

Key metrics and study information

142487
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.